COFCO Biotech reports decline in citric acid sales in H1 2024

On 24 Aug., COFCO Biotechnology Co., Ltd. (COFCO Biotech) issued its semi-annual report for H1 2024, with a slash in revenue of citric acids and the derivatives, which totalled USD48.25 million (RMB341.18 million), down by 35.02% YoY, representing 3....

Acidity Regulator Quarterly China Report Q3 2024

www.cnchemicals.com